Variant report
Variant | nsv441954 |
---|---|
Chromosome Location | chr5:53689472-53694167 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr5:53690607-53690687 | Kidney_OC | kidney: | n/a | n/a |
2 | EP300 | chr5:53691215-53691287 | K562 | blood: | n/a | n/a |
3 | MAFK | chr5:53691937-53692005 | HepG2 | liver: | n/a | n/a |
4 | MAFK | chr5:53691889-53691968 | Hela-S3 | cervix: | n/a | n/a |
5 | NFIC | chr5:53693931-53694409 | GM12878 | blood: | n/a | n/a |
6 | POLR2A | chr5:53689524-53689712 | K562 | blood: | n/a | n/a |
7 | POLR2A | chr5:53692863-53692895 | K562 | blood: | n/a | n/a |
8 | POLR2A | chr5:53691050-53691262 | K562 | blood: | n/a | n/a |
9 | POLR2A | chr5:53691714-53692321 | K562 | blood: | n/a | n/a |
10 | POLR2A | chr5:53693495-53694407 | K562 | blood: | n/a | n/a |
11 | POLR2A | chr5:53692555-53692950 | K562 | blood: | n/a | n/a |
12 | RUNX3 | chr5:53690430-53690783 | GM12878 | blood: | n/a | n/a |
13 | RUNX3 | chr5:53693936-53694505 | GM12878 | blood: | n/a | n/a |
14 | STAT3 | chr5:53692126-53692367 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:53686098..53687887-chr5:53688937..53691382,3 | K562 | blood: | |
2 | chr5:53604135..53610802-chr5:53683563..53694160,14 | K562 | blood: | |
3 | chr5:53680935..53682719-chr5:53693344..53694966,2 | K562 | blood: | |
4 | chr5:53692115..53693706-chr5:53696702..53699303,2 | K562 | blood: | |
5 | chr5:53605268..53607841-chr5:53691814..53694261,3 | K562 | blood: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HSPB3-1 | chr5:53692827-53692964 | ENSG00000249069.2 |
2 | lnc-HSPB3-1 | chr5:53691181-53691247 | ENSG00000249069.2 |
3 | lnc-HSPB3-1 | chr5:53691181-53691247 | ENSG00000249069.3 |
4 | lnc-HSPB3-1 | chr5:53692827-53692964 | ENSG00000249069.3 |
5 | lnc-HSPB3-1 | chr5:53692827-53692964 | ENSG00000249069.2 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL37P25 | TF binding region |
LINC01033 | TF binding region |
ENSG00000249069 | chromatin interactions |
ENSG00000185305 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs3111650 | chr5:53689474-53689475 | Weak transcription | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs555710530 | chr5:53689482-53689483 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs192594151 | chr5:53689529-53689530 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs113365093 | chr5:53689538-53689539 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs545046355 | chr5:53689591-53689592 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs560029113 | chr5:53689595-53689596 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs375544997 | chr5:53689630-53689631 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs542840043 | chr5:53689654-53689655 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs71600831 | chr5:53689676-53689677 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs60823008 | chr5:53689680-53689681 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs202177405 | chr5:53689682-53689683 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs200496615 | chr5:53689683-53689684 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs369705691 | chr5:53689684-53689685 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs201419519 | chr5:53689685-53689686 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs13362516 | chr5:53689708-53689709 | Weak transcription | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs140897290 | chr5:53689741-53689742 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs550082060 | chr5:53689755-53689756 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs368579900 | chr5:53689759-53689760 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs530410585 | chr5:53689819-53689820 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs150172163 | chr5:53689842-53689843 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs145441691 | chr5:53689843-53689844 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs184021683 | chr5:53689855-53689856 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs533978351 | chr5:53689867-53689868 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs371200896 | chr5:53689876-53689877 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs555567276 | chr5:53689902-53689903 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs567492308 | chr5:53689921-53689922 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs35646912 | chr5:53689929-53689930 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs543724719 | chr5:53689934-53689935 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs114132478 | chr5:53690002-53690003 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs141135588 | chr5:53690009-53690010 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs546722554 | chr5:53690010-53690011 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs373023807 | chr5:53690037-53690038 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs566843278 | chr5:53690094-53690095 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs187215859 | chr5:53690151-53690152 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs529302785 | chr5:53690156-53690157 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs577654969 | chr5:53690173-53690174 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs538302475 | chr5:53690196-53690197 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs192290258 | chr5:53690210-53690211 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs6859116 | chr5:53690216-53690217 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs146944852 | chr5:53690242-53690243 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs184676554 | chr5:53690276-53690277 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs190492518 | chr5:53690279-53690280 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs543700146 | chr5:53690294-53690295 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs138060343 | chr5:53690295-53690296 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs532517386 | chr5:53690317-53690318 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs560012810 | chr5:53690331-53690332 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs547511466 | chr5:53690356-53690357 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs559712602 | chr5:53690372-53690373 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs376682146 | chr5:53690379-53690380 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs368262502 | chr5:53690387-53690388 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Autism | 22495311 | CNVD |
Intellectual disability | 22102821 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral cancer | 21386901 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:53684600-53690400 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
2 | chr5:53687800-53690000 | Weak transcription | K562 | blood |
3 | chr5:53690000-53690400 | Enhancers | K562 | blood |
4 | chr5:53690400-53691200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr5:53690400-53693000 | Genic enhancers | K562 | blood |
6 | chr5:53693000-53694800 | Weak transcription | K562 | blood |